Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12 Colorectal Neoplasms 6 Neoplasms 4 Thyroid Neoplasms 3 Prostatic Neoplasms 3 Ovarian Neoplasms 2 Colonic Neoplasms 2 Unmet Fertility Information Needs 1 Thyroid Cancer, Papillary 1 Smoking Cessation 1 Patient Participation 1 Papillary Thyroid Microcarcinoma 1 Neuroma, Acoustic 1 Melanoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Healthy Volunteers 1 Depression 1 Dementia 1 Carcinoma, Renal Cell 1 Carcinoma, Medullary 1 Carcinoma, Intraductal, Noninfiltrating 1 COVID-19 1 Breast Carcinoma In Situ 1 Behavior 1 Advanced Cancer 1

Interventions

Standard of Care 6 Surveys and Questionnaires 2 Interviews as Topic 2 zaleplon 1 olanzapine-fluoxetine combination 1 Videotape Recording 1 Rehabilitation 1 Referral and Consultation 1 Olanzapine 1 Neoadjuvant Therapy 1 Health Services Needs and Demand 1 Fluoxetine 1 Decision Support Techniques 1 Counseling 1 Control Groups 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Advanced Cancer × Decision Support Techniques × Clear all

NCT04606238 2023-01-10

PETUPAL

University Hospital Heidelberg

Phase NA Unknown

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡